EGFR and cancer: Pi et al. devised a strategy to enhance the anticancer efficacy by targeting cancer cells with overexpressed epidermal growth factor receptor (EGFR) using GE11 peptide-conjugated selenium nanoparticles for the delivery of colchicine (Pi et al., 2017).